HQY Stock Recent News
HQY LATEST HEADLINES
NEW YORK CITY, NY / ACCESS Newswire / April 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK CITY, NY / ACCESS Newswire / April 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public.
HQY stock is down more than 13% YTD amid cyber threats and rising costs, but strong HSA fundamentals remain. Is it time to hold or fold?
New claims technology recognized for both automation and health AI from the Business Intelligence Group New claims technology recognized for both automation and health AI from the Business Intelligence Group
NEW YORK , April 14, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. So What: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK , April 14, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alarum Technologies Ltd. (NASDAQ: ALAR) between March 14, 2024 and August 26, 2024, both dates inclusive (the “Class Period”), of the important April 15, 2025 lead plaintiff deadline.
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public.
NEW YORK CITY, NY / ACCESS Newswire / April 10, 2025 / WHY: New York, N.Y., April 10, 2025.